Health

Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange   GENEVA, Switzerland – May 27, 2022 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company...

SAN DIEGO, May 27, 2022 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc. (Nasdaq:BTX) (“Brooklyn”), a biopharmaceutical company focused on exploring the role that cytokine, gene editing, and cell therapy can have...

NEW YORK, May 27, 2022 (GLOBE NEWSWIRE) -- Wounded Warriors Family Support presented Luis Remache of Manorville, New York, with a 2022 Ford F-150 mobility-equipped vehicle. Remache is medically retired...

MONTREAL, May 28, 2022 (GLOBE NEWSWIRE) -- After two years, Le Bal Rouge was back with a vengeance. This year’s fiery edition raised funds in support of MI4, the McGill...

Cambridge, MA U.S.A. (May 27, 2022) — Allarity Therapeutics, Inc. (“Allarity” or the “Company”), a clinical-stage pharmaceutical company developing novel oncology therapeutics together with drug-specific DRP® companion diagnostics for personalized...

Brampton, Ontario, May 27, 2022 (GLOBE NEWSWIRE) -- LifeLabs recently hosted the grand opening of its newest Patient Service Centre at 8315 Financial Drive in Southwest Brampton. The Honourable Prabmeet...

MILAN, May 26, 2022 /PRNewswire/ -- Olon, Leading API supplier, announces the creation of an R&D hub at its center in Milan, home to the Group's headquarters, paving the way for...

68% of patients receiving Kymriah in the ELARA trial experienced complete response, with an 86% overall response rate, along with a remarkable safety profile1 Sustained clinical benefit from Kymriah treatment...

The pharmaceutical group, present in 140 countries in the world, aims to raise standard of patient healthcare across the Middle East and Africa (MEA) region with innovative products and breakthrough...

PRESS RELEASEREGULATED INFORMATION27 May 2022, 06:00 pm CEST Ghent, Belgium – 27 May 2022 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), an innovator in the...